Clinical Trial Update: Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Abrocitinib for severe fatigue in adults with Post-COVID Condition; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Post-covid Condition

Drugs mentioned

• Cibinqo (abrocitinib)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Post-COVID Condition, Fatigue Symptom | Phase 2 | Status: ACTIVE_NOT_RECRUITING